Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.

Saved in:
Bibliographic Details
Title: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.
Authors: Ran Z; Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, Shanghai, China., Chen Y; The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China., Miao Y; The First Affiliated Hospital of Kunming Medical University, Kunming, China., Wang Y; West China Hospital of Sichuan University, Chengdu, China., Gao X; The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Zhong J; Shanghai Jiaotong University School of Medicine Ruijin Hospital, Shanghai, China., Ding X; The Affiliated Hospital of Qingdao University, Qingdao, China., Wang C; The First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Zhang X; The Second Hospital of Hebei Medical University, Shijiazhuang, China., Ding Y; The Renmin Hospital of Wuhan University, Wuhan, China., Hu N; The First Affiliated Hospital of Anhui Medical University, Hefei, China., Tang D; Eli Lilly and Company, Shanghai, China., Yu J; Eli Lilly and Company, Shanghai, China., Qian C; Eli Lilly and Company, Shanghai, China., Shen J; School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, China. shenjun@vip.163.com.
Source: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2026 Jul; Vol. 40 (4), pp. 733-745. Date of Electronic Publication: 2026 May 12.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-190X
DOI:10.1007/s40259-026-00776-y